Sarah Dayre Appointed Guerbet Senior VP, Technical Operations: Effective February 1, 2021

Sarah Dayre will report directly to David Hale, CEO of Guerbet*.

Sarah Dayre is a Doctor of Pharmacy and a graduate of ENSIC in France (Process engineering).

She has gained over 20 years’ experience of pharmaceutical manufacturing and the global supply chain working for AstraZeneca in Europe and Asia.

In 2017 Sarah Dayre was appointed head of operations of the Wuxi site in China, in charge of regional and global markets.

“Sarah is a leader with extensive pharmaceutical expertise and I’m delighted to welcome her to our Executive Committee, where she will play a key role in helping us to meet the ambitious organizational efficiency targets set for our industrial operations, required to achieve our transformation,” said David Hale.

*Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019.

Other Executives In the News

SourceGuerbet
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version